DeLong Mark Jeffrey
Apellis Pharmaceuticals, Inc. ยท Chief Business & Strat Officer
DeLong Mark Jeffrey is listed in public filings as officer: Chief Business & Strat Officer. This DeLong Mark Jeffrey insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Apellis Pharmaceuticals, Inc. (APLS). Investors use DeLong Mark Jeffrey's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $2.5M114.6k shares | SellFeb 11, 2026 | $8.2K368 shares | $22.15 | -- | |
| --115k shares | Grant / ExerciseJan 28, 2026 | Disclosure amount unavailable36.6k shares | -- | -- | |
| $1.7M78.4k shares | SellJan 22, 2026 | $73.4K3.4k shares | $21.77 | -- | |
| $1.6M81.7k shares | SellJan 20, 2026 | $26.4K1.3k shares | $19.79 | -- | |
| $1.8M83.1k shares | SellJan 13, 2026 | $39.5K1.8k shares | $22.19 | -- | |
| $1.6M82.5k shares | Grant / ExerciseJun 9, 2025 | $1.6M82.5k shares | $19.39 | -- |